| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6c904b7cbcbc1a39ee23f79426b3caa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98f5bc87320d5e6f71d64b6894c4df87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce500514b27086cd110c52add2072b3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3e84961809006898e23a8aef6980e52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91d67788b59ee0d43c5f30da382a7c0b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
| filingDate |
2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f543c2c1bc13e0e310e837eb0ce0fd06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1d587f958a18a52513b94452fab1434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71c511f81197ae312e8d0cfe620a2c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_402c52ba81a6c4795df1c70345e6c7ec |
| publicationDate |
2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012128586-A1 |
| titleOfInvention |
Method for treating chronic lymphocytic leukemia |
| abstract |
The present invention provides a method for treating a subject having chronic lymphocytic leukemia (CLL) comprising administering to the subject one or more agents that target cell surface membrane antigens expressed preferentially on cells of the proliferative compartment of a CLL clone of the subject to treat chronic lymphocytic leukemia in the subject. The present invention also provides a method for treating a subject having chronic lymphocytic leukemia comprising administering to the subject one or more agents that target cell surface membrane antigens expressed preferentially on cells of the “resting re-entry compartment” to treat chronic lymphocytic leukemia in the subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3062105-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016135273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016164743-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11224654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019135918-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107847547-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11231418-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11773166-B2 |
| priorityDate |
2009-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |